You are here

  • Home
  • Archive
  • Volume 10, Issue 12
  • Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy

 

Online download statistics by month:

Online download statistics by month: December 2022 to October 2025

AbstractFullPdf
Dec 202220520866
Jan 2023327330204
Feb 202316016186
Mar 202315215471
Apr 202315215266
May 202313213375
Jun 202314414448
Jul 202312012087
Aug 2023959657
Sep 202315515579
Oct 202311511562
Nov 202314214288
Dec 2023114114119
Jan 2024153154123
Feb 202410410469
Mar 2024154154165
Apr 2024153154119
May 2024113116100
Jun 202410811371
Jul 2024165166112
Aug 20241009774
Sep 202410810984
Oct 2024979764
Nov 202412512784
Dec 2024178186120
Jan 2025747468
Feb 2025194194112
Mar 2025202203137
Apr 2025162162119
May 2025107108108
Jun 2025707052
Jul 2025110
Sep 2025110
Oct 2025001
Total438244142890